 Maggie Lam
Concepts (245)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Proteomics | 26 | 2025 | 1062 | 4.880 |
Why?
| | Proteome | 17 | 2025 | 443 | 2.970 |
Why?
| | Myocardium | 11 | 2024 | 980 | 2.370 |
Why?
| | Alternative Splicing | 4 | 2024 | 218 | 2.120 |
Why?
| | Protein Isoforms | 3 | 2024 | 391 | 1.560 |
Why?
| | Proteins | 7 | 2025 | 942 | 1.540 |
Why?
| | Mitochondria, Heart | 7 | 2016 | 94 | 1.490 |
Why?
| | Bibliometrics | 3 | 2019 | 54 | 1.340 |
Why?
| | Muscle Proteins | 5 | 2016 | 220 | 1.000 |
Why?
| | Mitochondrial Proteins | 5 | 2015 | 248 | 0.930 |
Why?
| | Computational Biology | 2 | 2021 | 599 | 0.900 |
Why?
| | Intrinsically Disordered Proteins | 1 | 2024 | 30 | 0.870 |
Why?
| | Chromatography, Reverse-Phase | 3 | 2011 | 27 | 0.810 |
Why?
| | Proteogenomics | 1 | 2022 | 4 | 0.800 |
Why?
| | Data Mining | 3 | 2019 | 110 | 0.790 |
Why?
| | Cardiovascular Diseases | 3 | 2023 | 2004 | 0.750 |
Why?
| | Disease | 2 | 2020 | 95 | 0.730 |
Why?
| | Paraquat | 1 | 2020 | 15 | 0.700 |
Why?
| | Robotics | 1 | 2021 | 94 | 0.680 |
Why?
| | Mass Spectrometry | 9 | 2025 | 716 | 0.660 |
Why?
| | Heart Diseases | 1 | 2023 | 350 | 0.650 |
Why?
| | Semantics | 1 | 2018 | 100 | 0.580 |
Why?
| | Quinolines | 1 | 2018 | 156 | 0.540 |
Why?
| | Down Syndrome | 1 | 2023 | 479 | 0.520 |
Why?
| | Oxidative Stress | 2 | 2020 | 1269 | 0.500 |
Why?
| | Deuterium Oxide | 4 | 2025 | 16 | 0.490 |
Why?
| | Research | 2 | 2015 | 416 | 0.480 |
Why?
| | Cardiovascular System | 2 | 2016 | 137 | 0.460 |
Why?
| | Proteasome Endopeptidase Complex | 2 | 2014 | 148 | 0.450 |
Why?
| | Biomedical Research | 2 | 2018 | 638 | 0.450 |
Why?
| | Ubiquitination | 1 | 2014 | 98 | 0.450 |
Why?
| | Cardiology | 1 | 2016 | 261 | 0.440 |
Why?
| | Isoproterenol | 1 | 2014 | 115 | 0.430 |
Why?
| | Cyclophilins | 1 | 2013 | 41 | 0.430 |
Why?
| | Mice | 20 | 2025 | 16937 | 0.400 |
Why?
| | Biomarkers | 4 | 2021 | 3973 | 0.400 |
Why?
| | Glycopeptides | 2 | 2011 | 44 | 0.390 |
Why?
| | Lysine | 1 | 2014 | 286 | 0.380 |
Why?
| | Glycomics | 1 | 2011 | 7 | 0.380 |
Why?
| | Graphite | 1 | 2011 | 11 | 0.380 |
Why?
| | Animals | 28 | 2025 | 35360 | 0.370 |
Why?
| | Glycoproteins | 2 | 2010 | 338 | 0.370 |
Why?
| | Heart | 1 | 2014 | 637 | 0.340 |
Why?
| | Myocytes, Cardiac | 3 | 2022 | 499 | 0.290 |
Why?
| | Humans | 28 | 2024 | 129622 | 0.270 |
Why?
| | Amino Acid Sequence | 6 | 2014 | 2058 | 0.270 |
Why?
| | Isotope Labeling | 2 | 2025 | 74 | 0.250 |
Why?
| | Molecular Sequence Data | 5 | 2014 | 2832 | 0.240 |
Why?
| | Peptides | 4 | 2025 | 925 | 0.240 |
Why?
| | Tandem Mass Spectrometry | 3 | 2021 | 524 | 0.230 |
Why?
| | Tensins | 1 | 2024 | 5 | 0.230 |
Why?
| | LIM Domain Proteins | 1 | 2024 | 17 | 0.220 |
Why?
| | Aging | 3 | 2023 | 1776 | 0.220 |
Why?
| | Proteostasis | 1 | 2024 | 27 | 0.220 |
Why?
| | Heart Ventricles | 3 | 2024 | 781 | 0.210 |
Why?
| | Organ Specificity | 1 | 2024 | 296 | 0.210 |
Why?
| | Heart Atria | 1 | 2024 | 128 | 0.210 |
Why?
| | Databases, Protein | 2 | 2013 | 62 | 0.210 |
Why?
| | Transcriptome | 4 | 2022 | 887 | 0.200 |
Why?
| | Polysaccharides | 3 | 2011 | 86 | 0.190 |
Why?
| | Myofibrils | 1 | 2022 | 49 | 0.190 |
Why?
| | Sarcomeres | 1 | 2022 | 92 | 0.190 |
Why?
| | Muscle, Striated | 1 | 2021 | 6 | 0.190 |
Why?
| | Heart Failure | 3 | 2022 | 2149 | 0.190 |
Why?
| | Automation | 1 | 2021 | 82 | 0.180 |
Why?
| | Ventricular Remodeling | 2 | 2021 | 255 | 0.180 |
Why?
| | Male | 11 | 2023 | 63674 | 0.180 |
Why?
| | Cell Line | 3 | 2019 | 2781 | 0.180 |
Why?
| | Heart Murmurs | 1 | 2021 | 12 | 0.180 |
Why?
| | Blood Proteins | 2 | 2014 | 242 | 0.180 |
Why?
| | RNA-Binding Proteins | 2 | 2022 | 388 | 0.180 |
Why?
| | Cyclic N-Oxides | 1 | 2020 | 30 | 0.180 |
Why?
| | Equipment Design | 3 | 2011 | 513 | 0.180 |
Why?
| | RNA Splicing | 1 | 2022 | 262 | 0.180 |
Why?
| | Spin Labels | 1 | 2020 | 47 | 0.180 |
Why?
| | Laboratories | 1 | 2021 | 110 | 0.170 |
Why?
| | Chromatography, Liquid | 3 | 2012 | 423 | 0.170 |
Why?
| | Cell- and Tissue-Based Therapy | 1 | 2021 | 75 | 0.170 |
Why?
| | Specimen Handling | 1 | 2021 | 164 | 0.170 |
Why?
| | Embryonic Stem Cells | 1 | 2021 | 118 | 0.170 |
Why?
| | Protein Binding | 2 | 2024 | 2121 | 0.170 |
Why?
| | Pluripotent Stem Cells | 1 | 2021 | 77 | 0.170 |
Why?
| | Organophosphorus Compounds | 1 | 2020 | 79 | 0.170 |
Why?
| | Extracellular Matrix | 2 | 2021 | 504 | 0.160 |
Why?
| | Cardiomegaly | 2 | 2018 | 172 | 0.160 |
Why?
| | Doxorubicin | 1 | 2021 | 325 | 0.160 |
Why?
| | Histone Deacetylase Inhibitors | 1 | 2021 | 209 | 0.160 |
Why?
| | Signal Transduction | 1 | 2012 | 4925 | 0.160 |
Why?
| | Piperidines | 1 | 2020 | 198 | 0.150 |
Why?
| | Rheumatic Diseases | 1 | 2019 | 69 | 0.150 |
Why?
| | Proteolysis | 2 | 2025 | 166 | 0.150 |
Why?
| | Molecular Sequence Annotation | 1 | 2018 | 87 | 0.150 |
Why?
| | Myofibroblasts | 1 | 2019 | 121 | 0.150 |
Why?
| | Sex Characteristics | 1 | 2023 | 737 | 0.140 |
Why?
| | Phosphorylation | 2 | 2012 | 1713 | 0.140 |
Why?
| | Mitochondria | 2 | 2015 | 877 | 0.140 |
Why?
| | Induced Pluripotent Stem Cells | 1 | 2019 | 221 | 0.130 |
Why?
| | Early Diagnosis | 1 | 2018 | 234 | 0.130 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2019 | 442 | 0.130 |
Why?
| | Brain Chemistry | 1 | 2016 | 118 | 0.130 |
Why?
| | Alu Elements | 1 | 2016 | 27 | 0.130 |
Why?
| | Machine Learning | 1 | 2021 | 443 | 0.130 |
Why?
| | Autoimmune Diseases | 1 | 2019 | 426 | 0.120 |
Why?
| | Chromatin | 1 | 2019 | 479 | 0.120 |
Why?
| | Cell Differentiation | 2 | 2021 | 1902 | 0.120 |
Why?
| | Reproducibility of Results | 2 | 2021 | 3083 | 0.120 |
Why?
| | Primates | 1 | 2016 | 120 | 0.120 |
Why?
| | Eye | 1 | 2015 | 104 | 0.120 |
Why?
| | Nuclear Proteins | 1 | 2019 | 663 | 0.110 |
Why?
| | Hydrophobic and Hydrophilic Interactions | 2 | 2011 | 186 | 0.110 |
Why?
| | Mice, Inbred ICR | 1 | 2014 | 110 | 0.110 |
Why?
| | Female | 7 | 2023 | 68770 | 0.110 |
Why?
| | Chloroplasts | 2 | 2011 | 17 | 0.110 |
Why?
| | Acetylation | 1 | 2014 | 246 | 0.110 |
Why?
| | Knowledge Bases | 1 | 2013 | 24 | 0.110 |
Why?
| | Genome, Human | 1 | 2016 | 393 | 0.110 |
Why?
| | Systems Integration | 1 | 2013 | 38 | 0.110 |
Why?
| | Adrenergic beta-Agonists | 1 | 2014 | 132 | 0.100 |
Why?
| | Intestines | 1 | 2016 | 348 | 0.100 |
Why?
| | Systems Biology | 1 | 2013 | 59 | 0.100 |
Why?
| | Arabidopsis Proteins | 2 | 2011 | 68 | 0.100 |
Why?
| | Peptide Library | 1 | 2013 | 84 | 0.100 |
Why?
| | Mitochondria, Liver | 1 | 2012 | 74 | 0.100 |
Why?
| | Switzerland | 1 | 2012 | 36 | 0.100 |
Why?
| | Carbohydrate Conformation | 1 | 2011 | 15 | 0.100 |
Why?
| | Concanavalin A | 1 | 2011 | 75 | 0.090 |
Why?
| | Calcium Signaling | 1 | 2014 | 250 | 0.090 |
Why?
| | Protein Conformation | 1 | 2014 | 859 | 0.090 |
Why?
| | International Cooperation | 1 | 2012 | 174 | 0.090 |
Why?
| | Transcription Factors | 1 | 2019 | 1651 | 0.090 |
Why?
| | Peptide Hydrolases | 1 | 2012 | 107 | 0.090 |
Why?
| | Peptide Mapping | 1 | 2011 | 63 | 0.090 |
Why?
| | Chromatography, Ion Exchange | 1 | 2011 | 52 | 0.090 |
Why?
| | Cattle | 2 | 2010 | 976 | 0.090 |
Why?
| | Statistics, Nonparametric | 1 | 2011 | 422 | 0.090 |
Why?
| | Kinetics | 1 | 2014 | 1642 | 0.090 |
Why?
| | Protein Biosynthesis | 1 | 2012 | 406 | 0.080 |
Why?
| | Serum | 1 | 2010 | 58 | 0.080 |
Why?
| | Oryza | 1 | 2010 | 31 | 0.080 |
Why?
| | Plant Proteins | 1 | 2010 | 89 | 0.080 |
Why?
| | Conserved Sequence | 1 | 2010 | 227 | 0.080 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2010 | 372 | 0.080 |
Why?
| | Nitric Oxide Synthase | 1 | 2010 | 237 | 0.080 |
Why?
| | Arabidopsis | 1 | 2010 | 85 | 0.080 |
Why?
| | Models, Molecular | 1 | 2014 | 1492 | 0.080 |
Why?
| | Spectrometry, Mass, Electrospray Ionization | 1 | 2010 | 179 | 0.080 |
Why?
| | Kidney | 1 | 2016 | 1385 | 0.080 |
Why?
| | Liver | 1 | 2016 | 1839 | 0.070 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2010 | 582 | 0.070 |
Why?
| | Peptide Fragments | 1 | 2011 | 692 | 0.070 |
Why?
| | Algorithms | 1 | 2013 | 1622 | 0.060 |
Why?
| | Deuterium | 1 | 2025 | 87 | 0.060 |
Why?
| | Cell Line, Tumor | 1 | 2011 | 3215 | 0.050 |
Why?
| | Unfolded Protein Response | 1 | 2024 | 53 | 0.050 |
Why?
| | Golgi Apparatus | 1 | 2024 | 100 | 0.050 |
Why?
| | Lung | 1 | 2016 | 3931 | 0.050 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2021 | 2012 | 0.050 |
Why?
| | Histone Deacetylase 6 | 1 | 2022 | 17 | 0.050 |
Why?
| | Gene Expression Regulation | 2 | 2022 | 2548 | 0.050 |
Why?
| | Connectin | 1 | 2022 | 31 | 0.050 |
Why?
| | Cats | 1 | 2022 | 208 | 0.050 |
Why?
| | Rats | 2 | 2022 | 5499 | 0.050 |
Why?
| | Water | 1 | 2025 | 448 | 0.050 |
Why?
| | Disease Models, Animal | 2 | 2022 | 4063 | 0.050 |
Why?
| | Cardiotoxicity | 1 | 2021 | 33 | 0.050 |
Why?
| | Human Embryonic Stem Cells | 1 | 2021 | 23 | 0.050 |
Why?
| | Human Genome Project | 1 | 2020 | 15 | 0.040 |
Why?
| | Mice, SCID | 1 | 2021 | 351 | 0.040 |
Why?
| | Software | 1 | 2025 | 608 | 0.040 |
Why?
| | Teratoma | 1 | 2021 | 105 | 0.040 |
Why?
| | Cell Death | 1 | 2021 | 354 | 0.040 |
Why?
| | Stroke Volume | 1 | 2022 | 591 | 0.040 |
Why?
| | Azepines | 1 | 2019 | 89 | 0.040 |
Why?
| | Ventricular Function, Left | 1 | 2022 | 527 | 0.040 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2019 | 274 | 0.040 |
Why?
| | Homeostasis | 2 | 2012 | 611 | 0.040 |
Why?
| | Cell Adhesion Molecules | 1 | 2019 | 173 | 0.040 |
Why?
| | Reactive Oxygen Species | 1 | 2021 | 596 | 0.040 |
Why?
| | Atrial Remodeling | 1 | 2018 | 9 | 0.040 |
Why?
| | Enhancer Elements, Genetic | 1 | 2019 | 177 | 0.040 |
Why?
| | Mice, Inbred C57BL | 2 | 2019 | 5440 | 0.040 |
Why?
| | Triazoles | 1 | 2019 | 152 | 0.040 |
Why?
| | Mice, Inbred DBA | 1 | 2018 | 188 | 0.040 |
Why?
| | Osteoarthritis | 1 | 2019 | 167 | 0.030 |
Why?
| | Mice, Inbred Strains | 1 | 2018 | 406 | 0.030 |
Why?
| | Transforming Growth Factor beta | 1 | 2019 | 457 | 0.030 |
Why?
| | Fibrosis | 1 | 2019 | 520 | 0.030 |
Why?
| | RNA Polymerase II | 1 | 2019 | 317 | 0.030 |
Why?
| | RNA Editing | 1 | 2016 | 20 | 0.030 |
Why?
| | Adenosine Deaminase | 1 | 2016 | 29 | 0.030 |
Why?
| | Gene Regulatory Networks | 1 | 2018 | 284 | 0.030 |
Why?
| | RNA, Messenger | 1 | 2022 | 2708 | 0.030 |
Why?
| | RNA Stability | 1 | 2016 | 102 | 0.030 |
Why?
| | Mice, Inbred BALB C | 1 | 2018 | 1245 | 0.030 |
Why?
| | Epigenesis, Genetic | 1 | 2019 | 613 | 0.030 |
Why?
| | Species Specificity | 1 | 2016 | 575 | 0.030 |
Why?
| | Adult | 2 | 2014 | 35572 | 0.030 |
Why?
| | Exons | 1 | 2016 | 342 | 0.030 |
Why?
| | Mammals | 1 | 2016 | 271 | 0.030 |
Why?
| | Rats, Sprague-Dawley | 1 | 2019 | 2406 | 0.030 |
Why?
| | Software Design | 1 | 2013 | 23 | 0.030 |
Why?
| | Cell Proliferation | 1 | 2021 | 2391 | 0.030 |
Why?
| | Access to Information | 1 | 2013 | 47 | 0.030 |
Why?
| | Diffusion of Innovation | 1 | 2013 | 96 | 0.030 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2016 | 487 | 0.020 |
Why?
| | Half-Life | 1 | 2012 | 162 | 0.020 |
Why?
| | Workflow | 1 | 2013 | 155 | 0.020 |
Why?
| | Drosophila | 1 | 2013 | 143 | 0.020 |
Why?
| | Cytoprotection | 1 | 2012 | 56 | 0.020 |
Why?
| | Electrophoresis, Gel, Two-Dimensional | 1 | 2012 | 110 | 0.020 |
Why?
| | Enzyme Stability | 1 | 2012 | 69 | 0.020 |
Why?
| | Apoptosis | 1 | 2021 | 2503 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2019 | 4083 | 0.020 |
Why?
| | Muscle, Skeletal | 1 | 2021 | 1614 | 0.020 |
Why?
| | Oxidants | 1 | 2012 | 109 | 0.020 |
Why?
| | Automation, Laboratory | 1 | 2011 | 6 | 0.020 |
Why?
| | Substrate Specificity | 1 | 2012 | 368 | 0.020 |
Why?
| | Isoenzymes | 1 | 2012 | 302 | 0.020 |
Why?
| | Cations | 1 | 2011 | 80 | 0.020 |
Why?
| | Gene Expression Profiling | 1 | 2018 | 1706 | 0.020 |
Why?
| | Arthritis, Rheumatoid | 1 | 2019 | 1092 | 0.020 |
Why?
| | Embryo, Nonmammalian | 1 | 2011 | 166 | 0.020 |
Why?
| | Suppression, Genetic | 1 | 2010 | 25 | 0.020 |
Why?
| | Hydrogen Peroxide | 1 | 2012 | 318 | 0.020 |
Why?
| | Genetic Complementation Test | 1 | 2010 | 63 | 0.020 |
Why?
| | Horseradish Peroxidase | 1 | 2010 | 28 | 0.020 |
Why?
| | Energy Metabolism | 1 | 2016 | 874 | 0.020 |
Why?
| | Caenorhabditis elegans | 1 | 2013 | 291 | 0.020 |
Why?
| | Gene Expression Regulation, Plant | 1 | 2010 | 55 | 0.020 |
Why?
| | Ribonucleases | 1 | 2010 | 54 | 0.020 |
Why?
| | Trypsin | 1 | 2010 | 74 | 0.020 |
Why?
| | GTP Phosphohydrolases | 1 | 2010 | 85 | 0.020 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2011 | 544 | 0.020 |
Why?
| | Sequence Alignment | 1 | 2010 | 332 | 0.020 |
Why?
| | Solvents | 1 | 2010 | 108 | 0.020 |
Why?
| | Serum Albumin | 1 | 2010 | 149 | 0.020 |
Why?
| | Protein Transport | 1 | 2010 | 428 | 0.020 |
Why?
| | Zebrafish Proteins | 1 | 2011 | 265 | 0.020 |
Why?
| | RNA Interference | 1 | 2010 | 448 | 0.020 |
Why?
| | Recombinant Fusion Proteins | 1 | 2010 | 643 | 0.020 |
Why?
| | Fibroblasts | 1 | 2011 | 948 | 0.020 |
Why?
| | Genotype | 1 | 2010 | 1839 | 0.010 |
Why?
| | Mutation | 1 | 2010 | 3717 | 0.010 |
Why?
| | Young Adult | 1 | 2014 | 12426 | 0.010 |
Why?
| | Middle Aged | 1 | 2014 | 31150 | 0.010 |
Why?
|
|
Lam's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|